ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NuggMD Announces Winners of 2025 Patient Choice Awards

New York, NY (Newsworthy.ai) Thursday Apr 17, 2025 @ 12:10 PM Eastern —

More than 3,500 medical cannabis patients made their voices heard by voting for their favorite brands, products, and technologies in the 2025 NuggMD Patient Choice Awards.

NuggMD, the country’s leading telehealth platform for cannabis, today announced the winners and the runners-up across the 36 geographic regions and five base categories—products, brands, dispensaries, technologies, and creators—that were a part of the program. Entrants were sourced directly from cannabis consumers. There was no fee to enter or vote, removing unnecessary bias from the award process.

Trulieve, RISE, Rhythm, and Jeeter were among the brands that took home the top spot in multiple regional categories. Nationally, GravLabs won the Best Glassware category, while G Pen won for Best Vaporizer Hardware. Content creators @dope.as.yola, @dope_kitchen, and @pothead.princess won Gold, Silver, and Bronze, respectively, in the Best Content Creator category.

In total, patients selected winners and two runners-up for more than 350 categories.

“We set up the Patient Choice Awards to shine a spotlight on which brands and products are most popular regionally because, to cannabis consumers, that’s really all there is: a bunch of regional markets that operate relatively autonomously,” said Robert Brock, VP of marketing, NuggMD. “Despite the persistent torment of federal prohibition, entrepreneurship and grit is as alive as it’s ever been in the cannabis sector. Our awards program is, first and foremost, an opportunity to acknowledge and celebrate that.”

He continued: “Every cannabis business, from the largest multi-state operators to the smallest regional dispensaries and the most upstart brands, has a meaningful role to play in the industry’s development and maturation. We congratulate the winners, and we are grateful that so many patients participated.”

Voting took place from Feb. 25 to March 31. For a searchable directory of the winners, visit the Patient Choice Awards website.

About NuggMD

NuggMD is the leading medical marijuana technology platform in the United States, serving patients in 29 state-legal markets. Since the company’s founding in 2015, it has connected more than 2m patients with medical marijuana doctors via a state-of-the-art telehealth platform.

The company believes every human being has the right to explore the potential benefits of medical cannabis and is fully committed to helping each patient explore every option in their journey to wellness. For further information, visit http://www.nuggmd.com.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here NuggMD Announces Winners of 2025 Patient Choice Awards.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.